There has been a lot of discussion about a number of “on the horizon” drugs that are designed to aggressively treat advanced prostate cancer, including MDV3100. MDV3100 is supposed to act as a “super” antiandrogen (Casodex is the currently most used antiandrogen in the treatment of advanced prostate cancer). You may qualify to participate in [...]
The use of Ketoconazole (Keto) in men with advanced prostate cancer is not considered mainstream, however there is clear evidence that it does reduce PSA in men with castrate resistant prostate cancer. Currently, most men with advanced prostate cancer who do use Keto utilize it prior to chemotherapy. There has been little literature evaluating the [...]
We all have only the present time. Our past and our future are only thoughts in our mind. Make good use of the present so that the thoughts of the past are happy and the thoughts of the future are full of hope and expectation. Joel
In July the Department of Veterans Affairs (VA) sent out the first stipend payments to nearly 100 family caregivers of veterans, including men with prostate cancer. To qualify for the benefits the caregivers first had to complete a training program, “Comprehensive Assistance for Family Caregivers”. Qualified family caregivers receive an average $1,600 in monthly stipend [...]
Amgen has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the indication for denosumab (XGEVA) its RANK ligand inhibitor to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases. Although some doctors have already begun to use Xgeva in men with advanced prostate cancer, it is [...]